Abstract
This reanalysis of the Crystalloid versus Hydroxyethyl Starch Trial (CHEST), which compared 6% hydroxyethyl starch with 0.9% saline for fluid resuscitation in critically ill patients, confirms no significant difference in 90-day mortality between the trial groups.
Cite
CITATION STYLE
APA
Patel, A., Pieper, K., Myburgh, J. A., Perkovic, V., Finfer, S., Yang, Q., … Billot, L. (2017). Reanalysis of the Crystalloid versus Hydroxyethyl Starch Trial (CHEST). New England Journal of Medicine, 377(3), 298–300. https://doi.org/10.1056/nejmc1703337
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free